These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29796831)

  • 21. Opioids for persistent noncancer pain.
    McCleane G; Smith HS
    Anesthesiol Clin; 2007 Dec; 25(4):787-807, vi-ii. PubMed ID: 18054145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery.
    Gardell LR; King T; Ossipov MH; Rice KC; Lai J; Vanderah TW; Porreca F
    Neurosci Lett; 2006 Mar; 396(1):44-9. PubMed ID: 16343768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid Receptors.
    Stein C
    Annu Rev Med; 2016; 67():433-51. PubMed ID: 26332001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive effects of pluronic lecithin organo (PLO)-opioid gels in rats with thermal injury.
    Clifford JL; Christy RJ; Cheppudira BP
    Burns; 2017 Dec; 43(8):1709-1716. PubMed ID: 28778760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats.
    Lomas LM; Barrett AC; Terner JM; Lysle DT; Picker MJ
    Psychopharmacology (Berl); 2007 Apr; 191(2):273-85. PubMed ID: 17225166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure.
    Ossipov MH; Lai J; King T; Vanderah TW; Porreca F
    Biopolymers; 2005; 80(2-3):319-24. PubMed ID: 15795927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid and adjuvant analgesics: compared and contrasted.
    Khan MI; Walsh D; Brito-Dellan N
    Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of opioids for chronic pain: a review of the evidence.
    Ballantyne JC; Shin NS
    Clin J Pain; 2008; 24(6):469-78. PubMed ID: 18574357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid tolerance and hyperalgesia.
    Chang G; Chen L; Mao J
    Med Clin North Am; 2007 Mar; 91(2):199-211. PubMed ID: 17321281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperalgesia and opioid switching.
    Mercadante S; Arcuri E
    Am J Hosp Palliat Care; 2005; 22(4):291-4. PubMed ID: 16082916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pain in patients with opiates dependence].
    Courty P; Authier N
    Presse Med; 2012 Dec; 41(12 Pt 1):1221-5. PubMed ID: 23084179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation relative to morphine.
    Zadina JE; Nilges MR; Morgenweck J; Zhang X; Hackler L; Fasold MB
    Neuropharmacology; 2016 Jun; 105():215-227. PubMed ID: 26748051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
    Candiotti KA; Gitlin MC
    Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous opioid treatment for chronic noncancer pain: a time for moderation in prescribing.
    Colameco S; Coren JS; Ciervo CA
    Postgrad Med; 2009 Jul; 121(4):61-6. PubMed ID: 19641271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid-induced abnormal pain sensitivity.
    Mao J
    Curr Pain Headache Rep; 2006 Feb; 10(1):67-70. PubMed ID: 16499832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
    Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
    Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine-induced hyperalgesia in the rat.
    Wala EP; Holtman JR
    Eur J Pharmacol; 2011 Jan; 651(1-3):89-95. PubMed ID: 21114985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pain and opioids].
    Murányi M; Radák Z
    Orv Hetil; 2008 Dec; 149(50):2363-70. PubMed ID: 19073443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexmedetomidine infusion for the management of opioid-induced hyperalgesia.
    Belgrade M; Hall S
    Pain Med; 2010 Dec; 11(12):1819-26. PubMed ID: 21040434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.